Esperion Therapeutics, Inc. Income Statement
ESPR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Esperion Therapeutics, Inc. reported $403M in revenue and $23M in net loss for FY2025. Revenue has grown at a 18.1% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $403.1M | $332.3M | $116.3M | $75.5M | $78.4M | $227.5M | $148.4M | $0 | - | - | - | - | - | - | - |
| SG&A Expense | $165.8M | $163.1M | $142.5M | $109.1M | $185.0M | $199.6M | $65.9M | $33.1M | $21.4M | $18.3M | $20.2M | $10.9M | $6.7M | $2.2M | $2.4M |
| R&D Expense | $47.9M | $46.2M | $86.1M | $118.9M | $106.0M | $146.9M | $175.6M | $171.5M | $147.6M | $57.9M | $29.8M | $25.3M | $16.0M | $8.0M | $7.8M |
| Operating Income | $60.3M | $54.4M | -$155.6M | -$179.5M | -$226.7M | -$121.4M | -$93.1M | -$204.6M | -$169.0M | -$76.2M | -$50.0M | -$36.2M | -$22.8M | -$10.2M | -$10.2M |
| Interest Expense | - | - | $59.0M | $56.8M | $46.4M | $22.7M | $8.1M | $28.0K | $198.0K | $376.0K | $520.0K | $270.0K | $936.0K | $1.5M | $577.2K |
| Income Tax | $1.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$22.7M | -$51.7M | -$209.2M | -$233.7M | -$269.1M | -$143.6M | -$97.2M | -$201.8M | -$167.0M | -$75.0M | -$49.8M | -$36.4M | -$26.1M | -$11.7M | -$10.8M |
| EPS (Basic) | -$0.11 | -$0.28 | -$2.03 | -$3.52 | -$3.59 | $4.50 | $3.26 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.11 | -$0.28 | -$2.03 | -$3.52 | -$3.59 | $4.32 | $3.07 | - | - | - | - | - | - | - | - |
| Shares Outstanding | 207.9M | 187.2M | 103.1M | 66.4M | 27.1M | 27.5M | 26.8M | 26.8M | 23.9M | 22.5M | 22.0M | 16.4M | 7.9M | 323.4K | 298.7K |
| Operating Margin | 14.9% | 16.4% | -133.7% | -237.8% | -289.0% | -53.3% | -62.7% | - | - | - | - | - | - | - | - |
| Profit Margin | -5.6% | -15.6% | -179.9% | -309.6% | -343.0% | -63.1% | -65.5% | - | - | - | - | - | - | - | - |